A tuberculosis vaccine used in other parts of the world seemed, in a small new study, to be effective at preventing multiple sclerosis among people showing early signs of the condition. People showing early signs of multiple sclerosis -- a situation called clinically isolated syndrome -- who were randomized to received the Bacille Calmette-Guérin vaccine before undergoing multiple sclerosis treatment were less likely to develop multiple sclerosis, compared with those who received a placebo. The vaccine is used in other countries for tuberculosis prevention, though it is not used in the United States.
via Health News Headlines - Yahoo! News Read More Here..
No comments:
Post a Comment